Interhospital transports and mortality in patients with critical COVID-19: a single-centre cohort study

被引:0
|
作者
Agegard, Lina Toss [1 ]
Berggren, Karin [1 ,2 ]
Cronhjort, Maria [2 ,3 ]
Joelsson-Alm, Eva [1 ,2 ]
Sackey, Peter [4 ]
Jonmarker, Sandra [1 ,2 ]
Schandl, Anna Regina [1 ,2 ]
机构
[1] Soder Sjukhuset, Dept Perioperat & Intens Care, Stockholm, Sweden
[2] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden
[3] Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden
[4] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
来源
BMJ OPEN | 2025年 / 15卷 / 02期
关键词
COVID-19; Adult intensive & critical care; Safety; SEPSIS;
D O I
10.1136/bmjopen-2024-090952
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study aimed to compare mortality rates and length of hospital stay between patients with critical COVID-19 transferred to another hospital due to capacity constraints and those who remained at their initial admission hospital. Design Single-centre cohort study. Setting and participants 665 patients were treated for SARS-CoV-2 at two intensive care units (ICUs) in Stockholm, Sweden, from 1 March 2020 to 30 June 2021. Data on interhospital transfers (IHTs) were retrieved from medical records and patient data management systems according to predefined protocols. Main outcome measures The outcomes were 30-day and 90-day mortality, days alive and out of ICU. HR with 95% CI were calculated using Cox proportional hazard models with adjustments for age, sex, body mass index, severity of illness, comorbidity, invasive ventilation, treatment limitations and pandemic waves. Results Of 665 patients, 133 (20%) were transferred to another hospital. The mortality rate of transferred patients compared with non-transferred patients at 30 days was 19% vs 26% (p=0.13) and at 90 days 26% vs 30% (p=0.43). In the adjusted Cox regression analysis, IHT was associated with a lower mortality risk at 30 days (HR 0.47, 95% CI 0.30 to 0.76) and 90 days (HR 0.52, 95% CI 0.34 to 0.79). However, the number of days alive and out of ICU was significantly lower for the IHT group at 30 days. Conclusion In our study, IHT due to capacity constraints among critically ill COVID-19 patients was not associated with a higher mortality risk. The suitability for transfer was likely associated with lower mortality, although residual confounding cannot be ruled out. The requirement for invasive ventilation among transferred patients might account for the extended length of ICU stay, rather than the transfer itself. However, the difficulty in studying this issue lies in the fact that while patients are likely exposed to risks during transfer, they are simultaneously the patients stable enough to be transported.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre study
    Kremer, Wolfgang M.
    Labenz, Christian
    Kuchen, Robert
    Sagoschen, Ingo
    Bodenstein, Marc
    Schreiner, Oliver
    Woerns, Marcus A.
    Sivanathan, Visvakanth
    Weinmann, Arndt
    Galle, Peter R.
    Sprinzl, Martin F.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (01) : 169 - 179
  • [42] Acute intestinal ischemia in patients with COVID-19: single-centre experience and literature review
    Fransvea, P.
    Costa, G.
    Pepe, G.
    LA Greca, A.
    Magalini, S.
    Puccioni, C.
    D'agostino, L.
    Altieri, G.
    Borello, A.
    Cozza, V.
    Sganga, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (04) : 1414 - 1429
  • [43] Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study
    Kardos, Zsofia
    Szabo, Miklos
    Barath, Zsuzsanna
    Miksi, Agnes
    Olah, Csaba
    Kozma, Adam
    Gergely, Jozsef A.
    Csanky, Eszter
    Szekanecz, Zoltan
    BIOMEDICINES, 2023, 11 (02)
  • [44] Psychiatric complications of COVID-19 pneumonia: preliminary results of a single-centre prospective study
    Potapov, Pavel
    Yakovleva, Alexandra
    Volkov, Alexey
    Brovko, Michail
    Kinkulkina, Marina
    Tikhonova, Yulia
    Moiseev, Sergey
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [45] Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis: A single-centre study
    Singh, Pratima
    Behera, Debasis
    Gupta, Saurabh
    Deep, Akash
    Priyadarshini, Subhadra
    Padhan, Prasanta
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2022, 52 (02) : 100 - 104
  • [46] Markers predicting critical illness and mortality in COVID-19 patients: A multi-centre retrospective study
    Karaaslan, Tahsin
    Karatoprak, Cumali
    Karaaslan, Esra
    Kuzgun, Gulsah Sasak
    Gunduz, Mehmet
    Sekerci, Abdusselam
    Buyukaydin, Banu
    Ecder, Sabahat Alisir
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2021, 12 : 159 - 165
  • [47] Mid-regional pro-adrenomedullin as a predictor of in-hospital mortality in adult patients with COVID-19: a single-centre prospective study
    Popov, Dmitry
    Borovkova, Ulyana
    Rybka, Mikhail
    Ramnyonok, Tatiana
    Golukhova, Elena
    ANAESTHESIOLOGY INTENSIVE THERAPY, 2022, 54 (03) : 242 - 246
  • [48] Clinical and imaging characteristics of patients with COVID-19 predicting hospital readmission after emergency department discharge: a single-centre cohort study in Italy
    Galli, Maria Giulia
    Djuric, Olivera
    Besutti, Giulia
    Ottone, Marta
    Amidei, Lucia
    Bitton, Lee
    Bonilauri, Carlotta
    Boracchia, Luca
    Campanale, Sergio
    Curcio, Vittoria
    Lucchesi, Davide Maria Francesco
    Mulas, Cesare Salvatore
    Santi, Francesca
    Ferrari, Anna Maria
    Rossi, Paolo Giorgi
    Luppi, Francesco
    BMJ OPEN, 2022, 12 (04):
  • [49] Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study
    Xiong, Qiutang
    Xu, Ming
    Li, Jiao
    Liu, Yinghui
    Zhang, Jixiang
    Xu, Yu
    Dong, Weiguo
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (01) : 89 - 95
  • [50] Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study
    Hitchon, Carol A.
    Mesa, Christine
    Bernstein, Charles N.
    Marrie, Ruth Ann
    Card, Catherine
    O'Brien, Sheila F.
    Kim, John
    BMJ OPEN, 2023, 13 (05):